Skip to content

Duran AnCore® 620RG29 (UDI 00721902859793)Recalls & reported problems

Medtronic, Inc. · RING 620RG29 ANLO DURAN ANCORE CHORD 10L · Class 2 · Implant

All models of Duran AnCore (42)

Data updated Oct 16, 2026 from official FDA records · Editorial policy

Adverse event reports
6
Deaths reported
0
Injuries reported
6
Recalls naming it
0

Summary

The FDA's MAUDE database contains 6 adverse event reports that list this exact device (DI 00721902859793), received between Jan 30, 2019 and Feb 18, 2025 — classified as 6 injuries.

The most frequently reported specific device problem is “Insufficient Device Problem Information” (3 reports).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 0 reportsSep 2024: 0 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 2 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520262
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Insufficient Device Problem Information3
  • Patient Device Interaction Problem3
  • Gradient Increase1
  • Material Separation1

Patient problems

  • Atrial Fibrillation4
  • Atrial Flutter2
  • Mitral Valve Stenosis2
  • Non specific EKG/ECG Changes2
  • Tachycardia2
  • Corneal Pannus1
  • Host-Tissue Reaction1
  • Insufficient Information1

Recent adverse event reports

The 6 most recent of 6 reports, in the reporter's own words as published by the FDA.

  • InjuryFeb 18, 2025Patient Device Interaction Problem; Patient Device Interaction Problem

    MEDTRONIC RECEIVED INFORMATION THAT POST IMPLANT OF THIS 29MM MITRAL ANNULOPLASTY RING, A PERMANENT PACEMAKER WAS IMPLANTED. THE REASON FOR THE PERMANENT PACEMAKER WAS REPORTED AS INCOMPLETE ATRIOVENTRICULAR (AV) BLOCK AND ATRIAL ARRHYTHMIAS (ATRIAL TACHYCARDIA (AT), ATRIAL FIBRILLATION AND ATRIAL FLUTTER). NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Atrial Fibrillation; Atrial Flutter; Non specific EKG/ECG Changes; Tachycardia

    MAUDE report 21404370 ↗
  • InjuryFeb 13, 2025Patient Device Interaction Problem; Patient Device Interaction Problem

    MEDTRONIC RECEIVED INFORMATION THAT POST IMPLANT OF THIS 29MM MITRAL ANNULOPLASTY RING, A PERMANENT PACEMAKER WAS IMPLANTED. THE REASON FOR THE PERMANENT PACEMAKER WAS REPORTED AS INCOMPLETE ATRIOVENTRICULAR (AV) BLOCK AND ATRIAL ARRHYTHMIAS (ATRIAL TACHYCARDIA (AT), ATRIAL FIBRILLATION AND ATRIAL FLUTTER). NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Atrial Fibrillation; Atrial Flutter; Non specific EKG/ECG Changes; Tachycardia

    MAUDE report 21381263 ↗
  • InjuryJul 5, 2023Material Separation; Insufficient Device Problem Information; Material Separation; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT 1 YEAR AND 5 MONTHS POST IMPLANT OF THIS 29MM MITRAL ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH A 28MM MITRAL MECHANICAL VALVE. THE REASON FOR THE REPLACEMENT WAS NOT REPORTED. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Insufficient Information; Mitral Valve Insufficiency/ Regurgitation

    MAUDE report 17257761 ↗
  • InjuryJun 20, 2023Insufficient Device Problem Information; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT 1 DAY POST IMPLANT OF THIS 29MM MITRAL ANNULOPLASTY RING IMPLANTED IN THE AORTIC POSITION AT THE SUTURE LINE OF A 20MM UNKNOWN HOMOGRAFT, IT WAS REPORTED THAT THE PATIENT EXPERIENCED HEMODYNAMICALLY COMPROMISING ATRIAL FIBRILLATION THAT WAS CONVERTED WITH INTRAVENOUS AMIODARON, THEN ORAL AMIODARONE. MEDICATION WAS DISCONTINUED AFTER ONE WEEK. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Atrial Fibrillation

    MAUDE report 17162224 ↗
  • InjuryOct 15, 2019Patient Device Interaction Problem; Patient Device Interaction Problem

    MEDTRONIC RECEIVED INFORMATION THAT 11 YEARS AND 1 MONTH POST IMPLANT OF THIS 29MM MITRAL ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH A NON-MEDTRONIC MECHANICAL VALVE. THE REASON FOR REPLACEMENT WAS REPORTED AS SEVERE MITRAL STENOSIS. IT WAS ALSO NOTED THERE WAS PANNUS OVERGROWTH ON THE PATIENT'S NATIVE MITRAL VALVE. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Host-Tissue Reaction; Mitral Valve Stenosis

    MAUDE report 9192103 ↗
  • InjuryJan 30, 2019Gradient Increase; Insufficient Device Problem Information; Gradient Increase; Insufficient Device Problem Information

    MEDTRONIC RECEIVED INFORMATION THAT 5 YEARS 3 MONTHS POSTS IMPLANT OF THIS 29MM MITRAL ANNULOPLASTY RING, IT WAS EXPLANTED AND REPLACED WITH A NON MEDTRONIC BIOPROSTHETIC VALVE FOR UNKNOWN REASONS. NO ADDITIONAL ADVERSE PATIENT EFFECTS WERE REPORTED.

    Patient problems: Atrial Fibrillation; Corneal Pannus; Ischemia; Mitral Valve Stenosis; No Information

    MAUDE report 8289203 ↗

Other RING, ANNULOPLASTY devices

All RING, ANNULOPLASTY devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page